The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis

Figure 11

(a) The associations of STEAP1 expression and drug sensitivity based on CellMiner dataset were ordered according to value from small to large (ERK inhibitor: AZD-0364 and SCH-772984; MEK inhibitor: TAK-733, PD-0325901, trametinib, RO-5162766, RO-4987655, pimasertib, ARRY-162, cobimetinib (isomer1), ARRY-704, PD184352, and selumetinib; MET inhibitor: BMS-777607; and RTK inhibitor: sitravatinib). (b, c) The query score and interaction score for approved antineoplastic and immunotherapies of coexpressed genes with STEAP1.

(a)

(b)

(c)